We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC Clears Novartis-Eon Deal Pending Sale of Generic Products
FTC Clears Novartis-Eon Deal Pending Sale of Generic Products
July 26, 2005
The Federal Trade Commission (FTC) has tentatively approved Novartis’ acquisition of U.S. generic firm Eon Labs on the condition that Novartis sells three drug products to a competitor.